Archive for August, 2020

  • Invitation to a conference call and webcast by Isofol in connection with the entered license agreement with Solasia

    GOTHENBURG, Sweden, August 13, 2020 - Isofol Medical AB (publ) (“Isofol”), (Nasdaq First North Premier Growth Market: ISOFOL) has today…

    by
  • Isofol enters licensing agreement with Solasia to develop and commercialize arfolitixorin in Japan

    GOTHENBURG, Sweden, August 13, 2020 - Isofol Medical AB (publ) (“Isofol”), (Nasdaq First North Premier Growth Market: ISOFOL) today announced…

    by
  • Isofol’s CEO Ulf Jungnelius has subscribed for all warrants

    GOTHENBURG, Sweden, August 4, 2020 – Isofol Medical AB (http://isofol.se/en/) (publ) (Nasdaq First North Premier Growth Market: ISOFOL), today announced that…

    by